June 10, 2015 Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia PRS-080 Is Second Anticalin Successfully Administered to Humans

First Page		Document Content
Date: 2015-06-10 08:00:36		June 10, 2015 Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia PRS-080 Is Second Anticalin Successfully Administered to Humans Add to Reading List Source URL: content.stockpr.com Download Document from Source Website File Size: 39,33 KB Share Document on Facebook